Assignee
PIONYR IMMUNOTHERAPEUTICS INC
US·5 granted patents·5 pending applications·12 citations·filing 2018–2024
Top patents by PatentIndex Score
10 records- 0194US10508148B2Anti-TREM2 antibodies and related methodsPIONYR IMMUNOTHERAPEUTICS INC·Filed 2019·Granted Dec 17, 2019·11 cites·71 claims
- 0282US11505602B2Anti-TREM2 antibodies and related methodsPIONYR IMMUNOTHERAPEUTICS INC·Filed 2019·Granted Nov 22, 2022·1 cites·26 claims
- 0366US2024124588A1Compositions and methods for disabling myeloid cells expressing trem1PIONYR IMMUNOTHERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0464US11572407B2Anti-MARCO antibodies and uses thereofPIONYR IMMUNOTHERAPEUTICS INC·Filed 2021·Granted Feb 7, 2023·0 cites·58 claims
- 0564US2025179185A1Anti-trem1 antibodies and related methodsPIONYR IMMUNOTHERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0661US12065491B2Anti-TREM1 antibodies and related methodsPIONYR IMMUNOTHERAPEUTICS INC·Filed 2020·Granted Aug 20, 2024·0 cites·21 claims
- 0760US10836828B2Anti-TREM1 antibodies and related methodsPIONYR IMMUNOTHERAPEUTICS INC·Filed 2020·Granted Nov 17, 2020·0 cites·43 claims
- 0852US2024301059A1Fibrosis treatment with anti-trem2 antibodiesPIONYR IMMUNOTHERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0947US2020247889A1Compositions and methods for disabling myeloid cells expressing trem1PIONYR IMMUNOTHERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1047US2021317211A1Methods of using anti-trem2 antibodiesPIONYR IMMUNOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →